Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease

NCT04122469 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04122469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04122469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 11, 2019
Completion date
September 30, 2027
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic, genito-urinary, malignancy